Evidence of effectiveness of herbal medicinal products in the treatment of arthritis. Part 2: rheumatoid arthritis von Cameron, M, Gagnier, J.J, Little, C.V

Volltext

Improving the Quality of Reporting of Randomised Controlled Trials Evaluating Herbal Interventions: Implementing the Consort Statement von Gagnier, J.J., Boon, H., Rochon, P., Moher, D., Barnes, J., Bombardier, C.

Volltext

Measures of adult shoulder function von Buchbinder, R., Ramiro, S., Huang, H.M., Gagnier, J.J., Jia, Y.X., Whittle, S.L.

Volltext bestellen

CONSORT Harms 2022 statement, explanation, and elaboration: updated guideline for the reporting of harms in randomised trials von Junqueira, D.R, Zorzela, L, Golder, S, Loke, Y, Gagnier, J.J, Julious, S.A, Li, T, Mayo-Wilson, E, Pham, B, Phillips, R, Santaguida, P, Scherer, R.W, Gøtzsche, P.C, Moher, D, Ioannidis, J.P.A, Vohra, S

Volltext bestellen

CONSORT Harms 2022 statement, explanation, and elaboration: updated guideline for the reporting of harms in randomized trials von Junqueira, D.R, Zorzela, L, Golder, S, Loke, Y, Gagnier, J.J, Julious, S.A, Li, T, Mayo-Wilson, E, Pham, B, Phillips, R, Santaguida, P, Scherer, R.W, Gøtzsche, P.C, Moher, D, Ioannidis, J.P.A, Vohra, S, Evans, S, Fonfa, A, Lang, T.A, Loder, E, Weeks, L

Volltext bestellen

Which outcomes are most important to measure in patients with COVID-19 and how and when should these be measured? Development of an international standard set of outcomes measures... von Seligman, W.H, Fialho, L, Sillett, N, Nielsen, C, Baloch, F.M, Collis, P, Demedts, I.K.M, Fleck, M.P, Floriani, M.A, Gabriel, L.E.K, Gagnier, J.J, Keetharuth, A, Londral, A, Ludwig, I.I.L, Lumbreras, C, Moscoso Daza, A, Muhammad, N, Nader Bastos, G.A, Owen, C.W, Powers, J.H, Russell, A.-M, Smith, M.K, Wang, T.Y.-P, Wong, E.K, Woodhouse, D.C, Zimlichman, E, Brinkman, K

Volltext bestellen

Improving the quality of reporting randomized controlled trials evaluating herbal interventions: Implementing the CONSORT statement von Gagnier, J.J, Boon, H, Rochon, P, Moher, D, Barnes, J, Bombardier, C

Volltext

Ipilimumab alone or in combination with radiotherapy in metastatic castration-resistant prostate cancer: results from an open-label, multicenter phase I/II study von Slovin, S.F., Higano, C.S., Hamid, O., Tejwani, S., Harzstark, A., Alumkal, J.J., Scher, H.I., Chin, K., Gagnier, P., McHenry, M.B., Beer, T.M.

Volltext